Search filters

Authors whose works are in public domain in at least one jurisdiction

SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11)

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 07 December 2018
Author/s

author: Marc-Oliver Grimm  Martin Bögemann  Carsten Bokemeyer  Jens Bedke 

Publication date December 7, 2018
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item